( January 28, 2005 – Hong Kong) CK Life Sciences Int'l, (Holdings) Inc. (CK Life Sciences) was named Outstanding Biochemistry Technology Company in the 5th Outstanding Enterprise Awards organized by Capital magazine.
A total of 11 leading life sciences companies were nominated for this year's Outstanding Biochemistry Technology Company Award. The winner was decided by a vote by the general public (40%), a professional panel of judges (40%), and the editorial department of Capital magazine (20%). CK Life Sciences achieved the highest aggregate score in the ballot and earned the honour of the Award.
The Outstanding Biochemistry Technology Company was judged according to seven criteria, namely: product safety; product efficacy; legitimacy of product efficacy; business performance; authenticity of product testing; technological levels and investment in product research and development. CK Life Sciences' ability to distinguish itself from other companies in the biotechnology field is testimony to its outstanding performance in market development, standard of research, product quality and development and business prospects.
Prof S F Pang, Vice President and Chief Technology Officer of CK Life Sciences said, “We are greatly encouraged by the award of Outstanding Biochemistry Technology Company. This is evidence that the efforts we have put into our work in the past few years and our R&D results have been recognized by the community, providing us with the impetus to drive towards greater achievements in 2005.”
CK Life Sciences was established in 2000 and listed on the stock exchange in 2002. It has recorded rapid business progress and corporate expansion within a short period of time . In its short lifespan, CK Life Sciences has received a number of international awards and honours, for example being designated one of the world's 30 “2004 Technology Pioneers” by The World Economic Forum, which helped to introduce the expertise of local R&D and technological innovations to the international arena.
Prof Pang stated, “Ever since the establishment of CK Life Sciences, we have worked closely with the academic circle and international R&D institutions on studies targeting immunity, AIDS and cancer. We have collaborated with The Chinese University of Hong Kong, The Hong Kong University, The Hong Kong University of Science and Technology, Harvard Medical School, Cancer Institute and Hospital of the Chinese Academy of Medical Sciences, the China Cancer Research Foundation and The University of British Columbia. Results from various pre-clinical studies have indicated that the range of products developed by CK Life Sciences is able to enhance the immune system and suppress the growth of cancer cells. The satisfactory results demonstrate the feasibility of our R&D theories. These joint studies with academic institutes are instrumental in elevating local R&D to international standards and will facilitate its further development.”
“With regard to our environment related business, CK Life Sciences' eco-friendly fertilizer is now available in 13 countries and regions around the world. The product has provided farmers with a cost-effective solution that not only enhances crop yields and quality, but is also beneficial to the environment. CK Life Sciences is also currently promoting local organic vegetable farming, creating greater business opportunities for organic farmers in Hong Kong,” Prof Pang added.
“Building on satisfactory results and a solid foundation, we will concentrate our efforts in the new year on product distribution, R&D, product development and business acquisitions, in a bid to accelerate our growth and make greater contribution to Hong Kong's biotechnology industry,” Prof Pang concluded.
Apart from the category of Biochemistry Technology, outstanding companies were named in 13 other categories including Banking, Insurance, Logistics, Telecommunications and Restaurants Management.
Photo Caption :
Prof S F Pang, Vice President and Chief Technology Officer of CK Life Sciences, attended the 5th Outstanding Enterprise Awards Presentation Ceremony and was presented with the Outstanding Biochemistry Technology Company Award by Mr. Steven Cheung, Professor (Chair) of Finance Department of Economics & Finance, City University of Hong Kong.
About CK Life Sciences
CK Life Sciences Int'l., (Holdings) Inc. is a listed company on the Growth Enterprise Market of the Stock Exchange of Hong Kong with a market capitalization of about HK$7.9 billion as at the end of 2004 (stock code: 8222). Bearing the mission of improving the quality of life, the Group is engaged in the business of research and development, commercialization, marketing and sale of biotechnology products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. A number of the inventions have been granted patents by the US Patent and Trademark Office. The Group has also been selected as one of 30 global "Technology Pioneers 2004" by the World Economic Forum. (www.ck-lifesciences.com).